Workshop on Recent Challenges in Competition and IP in Pharmaceutical Markets


 26 February 2019  Paris  


Affordable access to many drugs is made difficult by high prices. At the same time, serious questions are being asked about the degree of innovation and value offered by increasingly costly treatments.

On 26 February 2019, the OECD will hold a one-day workshop in Paris to study the interaction between competition and IP rights in pharmaceutical markets.

Particular focus will be given to:

  • the role of competition in protecting innovation, and ;
  • patent strategies that seek to deter or delay the entry of generic medicines into the market, such as pay-for-delay, product-hopping, abuse of IP processes, ever-greening or patent clustering, among others. 

The workshop offers an opportunity to investigate the impact and role that IP rights play in the pharmaceutical sector while sharing experiences on how to address anticompetitive practices. We will also discuss the challenges of investigating and sanctioning such practices, and to identify potential best practices.  

Materials and more information on the speakers will soon become available on this page. 




Draft Agenda



Duncan MATTHEWS Bio   
Professor of Intellectual Property Law, Queen Mary University of London

Michael A. CARRIER Bio   
Professor of Law, Rutgers University



The workshop is open to government officials not only from competition authorities but also regulatory agencies in the sector. 

Invitations to our contacts have been sent by email. Participants will be able to self-register to this event in MyOECD and indicate if they wish to attend in person or via Webex (distant participation). If you have not received an invitation and would like to attend please contact Sofia Pavlidou.



Two other OECD events are being held back-to-back to this event. For more information:



Any questions related to the scope of the workshop should be sent to Pedro Caro de Sousa.

Questions regarding the logistics of the event can be sent to Sofia Pavlidou


Excessive Pricing in Pharmaceuticals, 2018

Generic pharmaceuticals and competition, 2014

Generic Pharmaceuticals, 2009

Intellectual Property Rights, 2004

Competition and Regulation Issues in the Pharmaceutical Industry, 2000

Competition Policy and Intellectual Property Rights, 1997 

All regulated sectors roundtables 

More work by the OECD Competition division 




Related Documents